SMTL ID : 5tob.1

Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

monomer

Ligands

1 x YAM: N-methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl}amino)methyl]pyridin-2-yl}methanesulfonamide(Non-covalent)

YAM.1: 15 residues within 4Å: Chain A: L.21, G.22, E.23, V.29, V.77, M.92, E.93, L.94, Y.95, G.98, E.99, R.143, N.144, L.146, D.157 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.21, A:L.146 Hydrogen bonds: A:Y.95, A:Y.95 Water bridges: A:E.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farand, J. et al., Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency. Bioorg. Med. Chem. Lett. (2016)

Release Date

2017-11-29

Peptides

Protein-tyrosine kinase 2-beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein-tyrosine kinase 2-beta

Related Entries With Identical Sequence